James Allison

March 1, 2018

Cancer immunotherapies expert Allison set for Discovery Lecture

James Allison, PhD, whose work led to the development of cancer immunotherapies known as “checkpoint inhibitors,” will deliver the next Flexner Discovery Lecture on Thursday, March 8.

By Leigh MacMillan